AIM
MRK icon

Acrospire Investment Management’s Merck MRK Stock Holding History

Acrospire Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,620
Closed -$160K – 893
2017
Q2 		$160K Buy
2,620
+1,782
+213% +$108K 0.15% 51
2017
Q1 		$51K Sell
838
-2,725
-76% -$165K 0.04% 934
2016
Q4 		$200K Buy
3,563
+1,153
+48% +$67.5K 0.08% 362
2016
Q3 		$144K Buy
2,410
+524
+28% +$30.6K 0.1% 292
2016
Q2 		$104K Buy
1,886
+104
+6% +$5.54K 0.08% 410
2016
Q1 		$90K Buy
+1,782
New +$87.3K 0.06% 399

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acrospire Investment Management's MRK Position: Q3 2017 in Review

Acrospire Investment Management sold out of Merck (MRK) in Q3 2017, closing a stake of 2,620 shares — an estimated $160K sold.

Acrospire Investment Management first reported a position in MRK in Q1 2016 and held it in 6 quarters. The position peaked at $200K in Q4 2016. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Acrospire Investment Management reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,620 Merck shares in Q3 2017, an estimated $160K.
  • Acrospire Investment Management first reported a position in Merck in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Merck position peaked at $200K in Q4 2016.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.